Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.790
+0.030 (0.80%)
At close: Apr 28, 2026, 4:00 PM EDT
3.770
-0.020 (-0.53%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Voyager Therapeutics Employees
Voyager Therapeutics had 141 employees as of December 31, 2025. The number of employees decreased by 31 or -18.02% compared to the previous year.
Employees
141
Change (1Y)
-31
Growth (1Y)
-18.02%
Revenue / Employee
$286,340
Profits / Employee
-$849,085
Market Cap
225.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
VYGR News
- 1 day ago - Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer's Disease - GlobeNewsWire
- 5 weeks ago - Voyager Therapeutics Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 7 weeks ago - Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Voyager to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Voyager Therapeutics Transcript: Stifel 2025 Healthcare Conference - Transcripts
- 6 months ago - Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia - GlobeNewsWire
- 6 months ago - Voyager Reports Third Quarter 2025 Financial and Operating Results - GlobeNewsWire